I agree with your comments. I also own BGL and EMR. Brought BGL at 80c and EMR at $1.18 and also at higher prices. Sold some EMR recently but still own over 70% of my purchase. Owned GOR when it was 5c and then 10c and sold half at 65c and then the rest at $1.40. GOR has done nothing in the last few years.
All had quality gold assets - one cannot go wrong buying upcoming gold producers with quality assets. Will probably sell some BGL (eg 25% to 30%) later this year or next year after it has been in full production for a while. Will keep EMR as it will probably have 3 producing assets in a few years which will only result in a higher SP.
Playing the Lassonde curve with quality projects can work very well.
I am still a little surprised that there was not a takeover of BGL - I guess with a quality asset BGL's SP has always had a high valuation so prospective buyers were scared off by its high SP.
I think there is the possibility the same will happen with SPR as it has a quality project - as long as the SPR SP remains strong then a possible takeover is less likely. I doubt SPR SP will be impacted much by the Lassonde curve heading into production - however its full value will only be achieved after its hits full production.
If SPR was able to produce 100k Oz pa at and AISC of about $1,000 we are looking at at least $200m in free cash flow for 10 years at current POG. That l result in a valuation much higher than today's SP maybe even $2. If they produced 150k Oz pa for 10 years than a SP of $3 is possible.
One of the reasons developers sell at lower prices is the need to raise considerable equity and debt to develop a mine but in SPR's case that need is limited - it is possible they may just raise debt to go back into production but another equity raising is possible.
- Forums
- ASX - By Stock
- SPR
- Ann: Surface drilling continues to unlock high grade potential
SPR
spartan resources limited
Add to My Watchlist
0.63%
!
$1.98

Ann: Surface drilling continues to unlock high grade potential, page-110
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.98 |
Change
-0.013(0.63%) |
Mkt cap ! $2.521B |
Open | High | Low | Value | Volume |
$2.01 | $2.05 | $1.95 | $8.493M | 4.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 33072 | $1.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.99 | 29567 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 75944 | 1.975 |
13 | 77207 | 1.970 |
13 | 57013 | 1.965 |
9 | 84397 | 1.960 |
9 | 78626 | 1.955 |
Price($) | Vol. | No. |
---|---|---|
1.980 | 16310 | 10 |
1.985 | 35424 | 17 |
1.990 | 54816 | 13 |
1.995 | 95452 | 10 |
2.000 | 101871 | 11 |
Last trade - 15.24pm 27/06/2025 (20 minute delay) ? |
Featured News
SPR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online